U.S Influenza Vaccines Market Worth US$ 8.3 billion by 2031
March 16, 2023 ⚊ 1 Min read ⚊ Views 84 ⚊ BUSINESSThe United States continues to be the world’s largest influenza vaccines market
Demand for influenza vaccines is expected to increase over the forecast period due to the pandemic COVID -19
Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, A Seasonal Influenza Vaccine Candidate
Novavax announces initiation of Phase 2 study for COVID-19 influenza combination vaccine and stand-alone influenza vaccine candidate
GSK and CureVac advance mRNA COVID-19 and influenza vaccine candidates
Seqirus receives a government contract to develop 2 influenza vaccines
Tags: vaccine